title: Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks.
abstract: Sa and the Sa/So ratio are very sensitive biomarkers of exposure to fumonisins in several species. We previously demonstrated that increases in Sa and in the Sa/So ratio in serum were less pronounced when ducks ingested fumonisins for more than 7 weeks than when animals were exposed for only 1-2 weeks [S.T. Tran, D. Tardieu, A. Auvergne, J.D. Bailly, R. Babilé, S. Durand, G. Benard, P. Guerre, Serum sphinganine and the sphinganine to sphingosine ratio as biomarker of dietary fumonisins during chronic exposure in ducks, Chem. Biol. Interact., in press]. The aim of this study was to investigate the kinetics of Sa and of the Sa/So in both liver and kidney of ducks that have been previously tested for Sa and the Sa/So ratio in serum. Analysis were performed on treatment days 0, 7, 14, 28 and 77 in five groups of ducks fed fumonisins obtained from an extract of Fusarium verticillioides culture material by daily gavage to obtain an exposure equal to 0, 2, 8, 32 and 128 mg FB1/kg feed. Sa and the Sa/So ratio in tissues were then correlated with Sa and the Sa/So ratio previously obtained in serum. The amounts on sphinganine 1-phosphate (Sa1P) and sphingosine1-phosphate (So1P) in the liver were also investigated. On day 7 of treatment, 2mg/kg FB1 in the feed were sufficient to increase Sa and the Sa/So ratio in liver (by 165 and 148%, respectively) and kidney (by 193 and 104%, respectively). At a rate of 128 mg/kg FB1 in the feed, a very high increase in Sa concentration was observed in both liver and kidney without mortality and/or signs of necrosis (respective increase of 2034 and 3768%). Although the precise mechanism of the resistance of ducks to fumonisin-induced hepatotoxicity is still uncertain, it might be linked to the rate at which the sphingoid bases sphinganine and sphingosine are converted to their 1-phosphate or other metabolite and eliminated from target tissues.
authors.affiliation: Department of Mycotoxicology, National Veterinary School of Toulouse, 23 Chemin des Capelles, 31076 Toulouse, France.
authors.forename: D
authors.initials: D
authors.lastname: Tardieu
authors.forename: S T
authors.initials: ST
authors.lastname: Tran
authors.forename: A
authors.initials: A
authors.lastname: Auvergne
authors.forename: R
authors.initials: R
authors.lastname: Babilé
authors.forename: G
authors.initials: G
authors.lastname: Benard
authors.forename: J D
authors.initials: JD
authors.lastname: Bailly
authors.forename: P
authors.initials: P
authors.lastname: Guerre
mesh_terms: D000284:Administration, Oral; D000818:Animals; D015415:Biomarkers / Q000097:blood; D002274:Carcinogens, Environmental / Q000493:pharmacokinetics / Q000633:toxicity*; D004032:Diet; D004305:Dose-Response Relationship, Drug; D004372:Ducks; D037341:Fumonisins / Q000493:pharmacokinetics / Q000633:toxicity*; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008246:Lysophospholipids / Q000378:metabolism; D009183:Mycotoxins; D009929:Organ Size / Q000187:drug effects; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000378:metabolism*; D018675:Toxicity Tests / Q000379:methods
chemical_list: D015415:Biomarkers; D002274:Carcinogens, Environmental; D037341:Fumonisins; D008246:Lysophospholipids; D009183:Mycotoxins; C060504:dihydrosphingosine 1-phosphate; C060506:sphingosine 1-phosphate; C056933:fumonisin B1; D013110:Sphingosine; C005682:safingol